{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:49:00Z","timestamp":1785908940112,"version":"3.56.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005416","name":"Research Council of Norway","doi-asserted-by":"publisher","award":["250993"],"award-info":[{"award-number":["250993"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Research Council of Norway","doi-asserted-by":"publisher","award":["287899"],"award-info":[{"award-number":["287899"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008730","name":"The Norwegian Cancer Society","doi-asserted-by":"publisher","award":["308811"],"award-info":[{"award-number":["308811"]}],"id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021492","name":"Inger and John Fredriksen Foundation for Ovarian Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"South-Eastern Norway Regional Health Authority","doi-asserted-by":"publisher","award":["2021082"],"award-info":[{"award-number":["2021082"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.neo.2026.101332","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T19:37:50Z","timestamp":1782416270000},"page":"101332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Fusion gene heterogeneity and kinase enrichment in high-grade serous carcinomas"],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2159-5341","authenticated-orcid":false,"given":"Ioannis","family":"Panagopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ane","family":"Stranger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8219-6251","authenticated-orcid":false,"given":"Anita","family":"Sveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mie","family":"Jareid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1789-7523","authenticated-orcid":false,"given":"Susanne G.","family":"Kidd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Bischof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjetil","family":"Task\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6274-2398","authenticated-orcid":false,"given":"Anne","family":"D\u00f8rum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1693-1032","authenticated-orcid":false,"given":"Ragnhild A.","family":"Lothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5609-4048","authenticated-orcid":false,"given":"Rolf I.","family":"Skotheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1749-7423","authenticated-orcid":false,"given":"Bjarne","family":"Johannessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.neo.2026.101332_bib0001","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S1470-2045(23)00335-2","article-title":"Tumour stage, treatment, and survival of women with high-grade serous tubo-ovarian cancer in UKCTOCS: an exploratory analysis of a randomised controlled trial","volume":"24","author":"Menon","year":"2023","journal-title":"Lancet Oncol."},{"issue":"7353","key":"10.1016\/j.neo.2026.101332_bib0002","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","year":"2011","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.neo.2026.101332_bib0003","doi-asserted-by":"crossref","first-page":"9509","DOI":"10.1007\/s00432-023-04748-5","article-title":"PARP inhibitors and overall survival in ovarian cancer, reevaluation advised in all settings","volume":"149","author":"Olivier","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.neo.2026.101332_bib0004","article-title":"Fusion genes in cancers: biogenesis, functions, and therapeutic implications","volume":"12","author":"Tang","year":"2025","journal-title":"Genes. Dis."},{"issue":"8","key":"10.1016\/j.neo.2026.101332_bib0005","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/s41587-022-01247-9","article-title":"Accurate detection of tumor-specific gene fusions reveals strongly immunogenic personal neo-antigens","volume":"40","author":"Weber","year":"2022","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.neo.2026.101332_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/bib\/bbac519","article-title":"Recent advances in cancer fusion transcript detection","volume":"24","author":"Dorney","year":"2023","journal-title":"Brief. Bioinform."},{"issue":"9","key":"10.1016\/j.neo.2026.101332_bib0007","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.3390\/ijms22094791","article-title":"Bosquet JG. Identification of novel fusion transcripts in high grade serous ovarian cancer","volume":"22","author":"Newtson","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"19","key":"10.1016\/j.neo.2026.101332_bib0008","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1093\/bioinformatics\/btab206","article-title":"FUNGI: fUsioN Gene Integration toolset","volume":"37","author":"Cervera","year":"2021","journal-title":"Bioinformatics"},{"issue":"3","key":"10.1016\/j.neo.2026.101332_bib0009","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.170423","article-title":"Evolutionary mode and timing of dissemination of high-grade serous carcinomas","volume":"9","author":"Sveen","year":"2024","journal-title":"JCI. Insight."},{"issue":"15","key":"10.1016\/j.neo.2026.101332_bib0010","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.neo.2026.101332_bib0011","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.neo.2026.101332_bib0012","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13059-019-1842-9","article-title":"Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods","volume":"20","author":"Haas","year":"2019","journal-title":"Genome Biol."},{"issue":"3","key":"10.1016\/j.neo.2026.101332_bib0013","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1101\/gr.257246.119","article-title":"Accurate and efficient detection of gene fusions from RNA sequencing data","volume":"31","author":"Uhrig","year":"2021","journal-title":"Genome Res."},{"key":"10.1016\/j.neo.2026.101332_bib0014","article-title":"FusionCatcher \u2013 a tool for finding somatic fusion genes in paired-end RNA-sequencing data","author":"Nicorici","year":"2014","journal-title":"bioRxiv"},{"issue":"D1","key":"10.1016\/j.neo.2026.101332_bib0015","doi-asserted-by":"crossref","first-page":"D1243","DOI":"10.1093\/nar\/gkae974","article-title":"The UCSC genome browser database: 2025 update","volume":"53","author":"Perez","year":"2025","journal-title":"Nucleic. Acids. Res."},{"issue":"4","key":"10.1016\/j.neo.2026.101332_bib0016","first-page":"656","article-title":"BLAT\u2013the BLAST-like alignment tool","volume":"12","author":"Kent","year":"2002","journal-title":"Genome Res."},{"issue":"D1","key":"10.1016\/j.neo.2026.101332_bib0017","doi-asserted-by":"crossref","first-page":"D20","DOI":"10.1093\/nar\/gkae979","article-title":"Database resources of the National Center for Biotechnology Information in 2025","volume":"53","author":"Sayers","year":"2025","journal-title":"Nucleic. Acids. Res."},{"issue":"2","key":"10.1016\/j.neo.2026.101332_bib0018","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq\u2013a Python framework to work with high-throughput sequencing data","volume":"31","author":"Anders","year":"2015","journal-title":"Bioinformatics"},{"issue":"12","key":"10.1016\/j.neo.2026.101332_bib0019","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"issue":"D1","key":"10.1016\/j.neo.2026.101332_bib0020","doi-asserted-by":"crossref","first-page":"D672","DOI":"10.1093\/nar\/gkae909","article-title":"KEGG: biological systems database as a model of the real world","volume":"53","author":"Kanehisa","year":"2025","journal-title":"Nucleic. Acids. Res."},{"issue":"4","key":"10.1016\/j.neo.2026.101332_bib0021","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/bioinformatics\/btl633","article-title":"Enrichment or depletion of a GO category within a class of genes: which test?","volume":"23","author":"Rivals","year":"2007","journal-title":"Bioinformatics"},{"issue":"D1","key":"10.1016\/j.neo.2026.101332_bib0022","doi-asserted-by":"crossref","first-page":"D966","DOI":"10.1093\/nar\/gkae1078","article-title":"GENCODE 2025: reference gene annotation for human and mouse","volume":"53","author":"Mudge","year":"2025","journal-title":"Nucleic. Acids. Res."},{"issue":"1","key":"10.1016\/j.neo.2026.101332_bib0023","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate - a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R Statist. Soc. B"},{"issue":"3","key":"10.1016\/j.neo.2026.101332_bib0024","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","article-title":"SciPy 1.0: fundamental algorithms for scientific computing in Python","volume":"17","author":"Virtanen","year":"2020","journal-title":"Nat. Methods"},{"issue":"5600","key":"10.1016\/j.neo.2026.101332_bib0025","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1126\/science.1075762","article-title":"The protein kinase complement of the human genome","volume":"298","author":"Manning","year":"2002","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.neo.2026.101332_bib0026","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41573-022-00582-5","article-title":"Beyond PI3Ks: targeting phosphoinositide kinases in disease","volume":"22","author":"Burke","year":"2023","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"D1","key":"10.1016\/j.neo.2026.101332_bib0027","doi-asserted-by":"crossref","first-page":"D334","DOI":"10.1093\/nar\/gkad1030","article-title":"TFCheckpoint database update, a cross-referencing system for transcription factors from human, mouse and rat","volume":"52","author":"Acencio","year":"2024","journal-title":"Nucleic. Acids. Res."},{"issue":"4","key":"10.1016\/j.neo.2026.101332_bib0028","doi-asserted-by":"crossref","first-page":"lqad093","DOI":"10.1093\/nargab\/lqad093","article-title":"Pathogenic signal peptide variants in the human genome","volume":"5","author":"Gutierrez Guarnizo","year":"2023","journal-title":"NAR. Genom. Bioinform."},{"issue":"260","key":"10.1016\/j.neo.2026.101332_bib0029","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/01621459.1952.10483441","article-title":"Use of ranks in one-criterion variance analysis","volume":"47","author":"Kruskal","year":"1952","journal-title":"J. Am. Stat. Assoc."},{"issue":"293","key":"10.1016\/j.neo.2026.101332_bib0030","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/01621459.1961.10482090","article-title":"Multiple comparisons among means","volume":"56","author":"Dunn","year":"1961","journal-title":"J. Am. Stat. Assoc."},{"issue":"2","key":"10.1016\/j.neo.2026.101332_bib0031","first-page":"65","article-title":"A simple sequentially rejective multiple test procedure","volume":"6","author":"Holm","year":"1979","journal-title":"Scand J Stat"},{"key":"10.1016\/j.neo.2026.101332_bib0032","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.omtn.2020.01.023","article-title":"Pan-cancer analysis reveals the diverse landscape of novel sense and antisense fusion transcripts","volume":"19","author":"Vellichirammal","year":"2020","journal-title":"Mol. Ther. Nucleic. Acids."},{"issue":"1","key":"10.1016\/j.neo.2026.101332_bib0033","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/path.2696","article-title":"Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary","volume":"221","author":"Ahmed","year":"2010","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.neo.2026.101332_bib0034","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1038\/s41467-023-39867-7","article-title":"The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma","volume":"14","author":"Smith","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neo.2026.101332_bib0035","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1514471","article-title":"Case report: high-grade serous tubo-ovarian carcinoma with FGFR2::IQCG fusion and insights into targetability","volume":"14","author":"Sono","year":"2024","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.neo.2026.101332_bib0036","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12943-018-0886-x","article-title":"A new ALK isoform transported by extracellular vesicles confers drug resistance to melanoma cells","volume":"17","author":"Cesi","year":"2018","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.neo.2026.101332_bib0037","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.celrep.2018.03.050","article-title":"Driver fusions and their implications in the development and treatment of human cancers","volume":"23","author":"Gao","year":"2018","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.neo.2026.101332_bib0038","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1158\/1541-7786.MCR-18-1075","article-title":"Discovery and characterization of recurrent, targetable ALK fusions in leiomyosarcoma","volume":"17","author":"Davis","year":"2019","journal-title":"Mol. Cancer Res."},{"issue":"4","key":"10.1016\/j.neo.2026.101332_bib0039","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/s41375-023-01843-x","article-title":"Unusual PDGFRB fusion reveals novel mechanism of kinase activation in Ph-like B-ALL","volume":"37","author":"Sadras","year":"2023","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.neo.2026.101332_bib0040","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201845947","article-title":"Translation acrobatics: how cancer cells exploit alternate modes of translational initiation","volume":"19","author":"Sriram","year":"2018","journal-title":"EMBO Rep."},{"issue":"2","key":"10.1016\/j.neo.2026.101332_bib0041","doi-asserted-by":"crossref","first-page":"zcae026","DOI":"10.1093\/narcan\/zcae026","article-title":"Non-canonical mRNA translation initiation in cell stress and cancer","volume":"6","author":"Mahe","year":"2024","journal-title":"NAR. Cancer"},{"issue":"4","key":"10.1016\/j.neo.2026.101332_bib0042","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/13543776.2025.2463150","article-title":"A patent review of BRD4 inhibitors (2020-present)","volume":"35","author":"Chen","year":"2025","journal-title":"Expert. Opin. Ther. Pat."},{"issue":"10","key":"10.1016\/j.neo.2026.101332_bib0043","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1080\/13543776.2024.2400166","article-title":"An updated patent review of BRD4 degraders","volume":"34","author":"Ma","year":"2024","journal-title":"Expert. Opin. Ther. Pat."},{"issue":"2","key":"10.1016\/j.neo.2026.101332_bib0044","first-page":"15","article-title":"mTOR inhibitors at a glance","volume":"7","author":"Zheng","year":"2015","journal-title":"Mol. Cell Pharmacol."},{"issue":"23","key":"10.1016\/j.neo.2026.101332_bib0045","doi-asserted-by":"crossref","first-page":"7376","DOI":"10.3390\/molecules26237376","article-title":"A review of HER4 (ErbB4) kinase, its impact on cancer, and its inhibitors","volume":"26","author":"El-Gamal","year":"2021","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.neo.2026.101332_bib0046","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/14728222.2024.2326211","article-title":"Considerations on the implementation of MAP4K4 inhibitors as cancer treatment","volume":"28","author":"Gonzalez-Montero","year":"2024","journal-title":"Expert. Opin. Ther. Targets."},{"issue":"5","key":"10.1016\/j.neo.2026.101332_bib0047","doi-asserted-by":"crossref","first-page":"5824","DOI":"10.1021\/acs.jmedchem.4c03158","article-title":"Discovery of potent and selective MNK kinase inhibitors for the treatment of leukemia","volume":"68","author":"Vagadia","year":"2025","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.neo.2026.101332_bib0048","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1021\/acs.jmedchem.2c01599","article-title":"Small molecule inhibitors of protein kinase D: early development, current approaches, and future directions","volume":"66","author":"Wang","year":"2023","journal-title":"J. Med. Chem."}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147655862600062X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147655862600062X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:18:49Z","timestamp":1785907129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147655862600062X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":48,"alternative-id":["S147655862600062X"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2026.101332","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fusion gene heterogeneity and kinase enrichment in high-grade serous carcinomas","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2026.101332","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101332"}}